DANIEL GENTRY: Open Payments
NPI 1093231755 · BALTIMORE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$444 in 14 payments from 10 companies in 2025. Trend: 2023 $300 · 2024 $300 · 2025 $444
Food & beverage: $444
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation | 2 | $181 |
| ABBVIE INC. | 2 | $50 |
| 180 Medical, Inc. | 2 | $46 |
| Sumitomo Pharma America, Inc. | 2 | $44 |
| Valencia Technologies Corporation | 1 | $26 |
| UROGEN PHARMA, INC. | 1 | $25 |
| Merck Sharp & Dohme LLC | 1 | $21 |
| Ferring Pharmaceuticals Inc. | 1 | $19 |
| Photocure Inc | 1 | $16 |
| Profound Medical Corp. | 1 | $15 |
Products named: AMS 700, BOTOX, GEMTESA, Rezum Generator, eCoin Device Kit, JELMYTO, SPEEDICATH, GENTLECATH.
Industry payments across MD — which companies pay providers there.
